The Oncosearch | Oncotarget

Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review Review

Muhamad N.A. Kamarudin, Ishwar Parhar

Published Jun 11, 2019 · Vol. 10, No. 39 · pp. 3952-3977

Keywords: glioma, anti-psychotic drugs, typical anti-psychotic, atypical anti-psychotic, valproic acid

Flow based single cell analysis of the immune landscape distinguishes Barrett’s esophagus from adjacent normal tissue Research Paper

Moen Sen, Friedrich Hahn, Taylor A. Black, Maureen DeMarshall, Warren Porter, Eileen Snowden, Stephanie S. Yee, Frances Tong, Mitchell Ferguson, Emylee N. Fleshman, Hiroshi Nakagawa, Gary W. Falk, Gregory G. Ginsberg, Michael L. Kochman, Rainer Blaesius, Anil K. Rustgi, Erica L. Carpenter

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3592-3604

Keywords: Barrett’s esophagus, microenvironment, immune cells, single cell, flow cytometry

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer Research Paper

Sandeep Rajput, Zhanfang Guo, Shunqiang Li, Cynthia X. Ma

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3667-3680

Keywords: PI3K inhibitor, BKM120, eribulin, triple-negative breast cancer, patient-derived xenograft

Association study of apelin-APJ system genetic polymorphisms with incident metabolic syndrome in a Chinese population: a case-control study Research Paper

Meijin Zhang, Feng Peng, Liming Lin, Mingzhong Yu, Chengyuan Huang, Dan Hu, Qinghui Guo, Changsheng Xu, Jinxiu Lin

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3807-3817

Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes Research Paper

Nadin D. Exner, Jaime Alberto Campos Valenzuela, Khalil Abou-El-Ardat, Hrvoje Miletic, Peter C. Huszthy, Petra M. Radehaus, Evelin Schröck, Rolf Bjerkvig, Lars Kaderali, Barbara Klink, Janice M. Nigro

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3641-3653

Keywords: exome sequencing, IDH1, oligodendroglioma, SNV, xenograft

The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells Research Paper

Kathryn Clarke, Christine Young, Fabio Liberante, Mary-Frances McMullin, Alexander Thompson, Ken Mills

Published May 28, 2019 · Vol. 10, No. 37 · pp. 3462-3471

Keywords: HDAC inhibitor, epigenetic, transcriptional regulation, myelodysplastic syndrome (MDS)

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Faruck L. Hakkim, Hamid A. Bakshi, Shabia Khan, Mohamad Nasef, Rabia Farzand, Smitha Sam, Luay Rashan, Mohammed S. Al-Baloshi, Sidgi Syed Anwar Abdo Hasson, Ali Al Jabri, Paul A. McCarron, Murtaza M. Tambuwala

Published May 28, 2019 · Vol. 10, No. 37 · pp. 3472-3490

Keywords: melanoma, frankincense, essential oil, apoptosis, tumor remission

Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes Research Paper

Nicole E. James, Lindsey Beffa, Matthew T. Oliver, Ashley D. Borgstadt, Jenna B. Emerson, Clinton O. Chichester, Naohiro Yano, Richard N. Freiman, Paul A. DiSilvestro, Jennifer R. Ribeiro

Published May 21, 2019 · Vol. 10, No. 36 · pp. 3315-3327

Keywords: DUSP6, HE4, ovarian cancer, chemoresistance, ERK signaling

Melanoma patients with additional primary cancers: a single-center retrospective analysis Research Paper

Florentia Dimitriou, Joanna Mangana, Alessandra Curioni-Fontecedro, Markus Rechsteiner, Patrick Turko, Ralph P. Braun, Reinhard Dummer, Phil F. Cheng

Published May 21, 2019 · Vol. 10, No. 36 · pp. 3373-3384

Keywords: melanoma, additional primary tumors, multiple primary tumors, BRAF V600E mutation, papillary thyroid cancer

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma Meta-Analysis

Ling Wang, Hung Lam, Yaping Shou, Aaron Galaznik

Published May 14, 2019 · Vol. 10, No. 35 · pp. 3285-3293

Keywords: diffuse large B-cell lymphoma, meta-analyses, outcomes, overall response rate, durable response rate

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Faruck L. Hakkim, Hamid A. Bakshi, Shabia Khan, Mohamad Nasef, Rabia Farzand, Smitha Sam, Luay Rashan, Al-Balushi MS, Hasson SS, Ali Al Jabri, Paul A McCarron, Murtaza M Tambuwala

Published May 3, 2019

Keywords: melanoma, frankincense, essential oil, apoptosis, tumor remission

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Faruck L. Hakkim, Hamid A. Bakshi, Shabia Khan, Mohamad Nasef, Rabia Farzand, Smitha Sam, Luay Rashan, Al-Balushi MS, Hasson SS, Ali Al Jabri, Paul A McCarron, Murtaza M Tambuwala

Published May 3, 2019

Keywords: melanoma, frankincense, essential oil, apoptosis, tumor remission

Differential microglia and macrophage profiles in human IDH-mutant and -wild type glioblastoma Research Paper

Candice C. Poon, Paul M.K. Gordon, Katherine Liu, Runze Yang, Susobhan Sarkar, Reza Mirzaei, Shiekh Tanveer Ahmad, Martha L. Hughes, V. Wee Yong, John J.P. Kelly

Published May 3, 2019 · Vol. 10, No. 33 · pp. 3129-3143

Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins Research Paper

Nicole E. James, Evelyn Cantillo, Naohiro Yano, Clinton O. Chichester, Paul A. DiSilvestro, Virginia Hovanesian, R. Shyama Prasad Rao, Kyukwang K. Kim, Richard G. Moore, Nagib Ahsan, Jennifer R. Ribeiro

Published Apr 26, 2019 · Vol. 10, No. 31 · pp. 2959-2972

Keywords: ovarian cancer, proteomics, septin-2, metabolic proteins

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients Research Paper

Elena Castellanos-Rizaldos, Xuan Zhang, Vasisht R. Tadigotla, Dominik G. Grimm, Chris Karlovich, Luis E. Raez, Johan K. Skog

Published Apr 23, 2019 · Vol. 10, No. 30 · pp. 2911-2920

Keywords: liquid biopsy, exosomes, ctDNA, exoNA, NSCLC

Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules Research Paper

Patrik Sundström, Louis Szeponik, Filip Ahlmanner, Malin Sundquist, Justin S.B. Wong, Elinor Bexe Lindskog, Bengt Gustafsson, Marianne Quiding-Järbrink

Published Apr 19, 2019 · Vol. 10, No. 29 · pp. 2810-2823

Keywords: tumor immunity, MAIT cells, cytotoxicity, colon adenocarcinoma, granzyme B

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts Research Paper

Jesus Delgado-Calle, Noriyoshi Kurihara, Emily G. Atkinson, Jessica Nelson, Kazuaki Miyagawa, Carlos Maria Galmarini, G. David Roodman, Teresita Bellido

Published Apr 12, 2019 · Vol. 10, No. 28 · pp. 2709-2721

Keywords: myeloma, osteoclasts, osteocytes, osteoblasts, tumor

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours Research Paper

Liliana D. Ordonez, Trevor Hay, Robert McEwen, Urszula M. Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo, Lucy Silcock, Elisabetta Leo, Mark J. O’Connor, Alan R. Clarke, Matthew J. Smalley

Published Apr 5, 2019 · Vol. 10, No. 27 · pp. 2586-2606

Keywords: PARP inhibitors, olaparib, Brca2, EMT, P-gps

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Liliana D. Ordonez, Trevor Hay, Robert McEwen, Urszula M. Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo, Lucy Silcock, Elisabetta Leo, Mark J. O’Connor, Alan R. Clarke, Matthew J. Smalley

Published Mar 27, 2019

Keywords: PARP inhibitors, olaparib, Brca2, EMT, P-gps

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Liliana D. Ordonez, Trevor Hay, Robert McEwen, Urszula M. Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo, Lucy Silcock, Elisabetta Leo, Mark J. O’Connor, Alan R. Clarke, Matthew J. Smalley

Published Mar 27, 2019

Keywords: PARP inhibitors, olaparib, Brca2, EMT, P-gps

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review Review

Flow based single cell analysis of the immune landscape distinguishes Barrett’s esophagus from adjacent normal tissue Research Paper

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer Research Paper

Association study of apelin-APJ system genetic polymorphisms with incident metabolic syndrome in a Chinese population: a case-control study Research Paper

Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes Research Paper

The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells Research Paper

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes Research Paper

Melanoma patients with additional primary cancers: a single-center retrospective analysis Research Paper

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma Meta-Analysis

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Differential microglia and macrophage profiles in human IDH-mutant and -wild type glioblastoma Research Paper

Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins Research Paper

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients Research Paper

Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules Research Paper

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review Review

Flow based single cell analysis of the immune landscape distinguishes Barrett’s esophagus from adjacent normal tissue Research Paper

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer Research Paper

Association study of apelin-APJ system genetic polymorphisms with incident metabolic syndrome in a Chinese population: a case-control study Research Paper

Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes Research Paper

The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells Research Paper

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes Research Paper

Melanoma patients with additional primary cancers: a single-center retrospective analysis Research Paper

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma Meta-Analysis

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Differential microglia and macrophage profiles in human IDH-mutant and -wild type glioblastoma Research Paper

Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins Research Paper

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients Research Paper

Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules Research Paper

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper